Cooper Companies Inc
COO · Health Technology · Medical Specialties · US
15,000 employees · coopercos.com
About
CooperVision, a division of The Cooper Cos, Inc., generates revenue through the sale of soft contact lenses including single-use, two-week, and monthly options across spherical, aspherical, toric, and multifocal varieties. These products are distributed globally in the Americas, EMEA, and Asia Pacific regions, manufactured at facilities in the UK, Puerto Rico, Hungary, Costa Rica, and New York. CooperSurgical, the other business unit, provides women's health, fertility, and diagnostic solutions, serving healthcare providers and institutions focused on family health advancement. The company's revenue streams are derived from direct sales to eye care professionals and healthcare institutions purchasing these specialized medical devices and services.
Annual results
Reported figures, USD · revenue up 5.1% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 4.1B | 374M | 9.1% | 434M |
| 2024 | 3.9B | 392M | 10.1% | 288M |
| 2023 | 3.6B | 294M | 8.2% | 215M |
| 2022 | 3.3B | 385M | 11.6% | 450M |
| 2021 | 2.9B | 2.9B | 100.8% | 524M |
Dividends per share
COO in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Cooper Companies Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.